Globus Medical Inc
NYSE:GMED
Globus Medical Inc
NYSE:GMED
Price:
64.72 USD
0.56%
Market Closed
Updated:
May 12, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
4.4
Current
5.6
Median
2.5
Industry
Lower
than median
Higher
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=4.4
Enterprise Value
/
8.3B
Revenue
1.9B
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| US |
|
Globus Medical Inc
NYSE:GMED
|
8.7B USD | 4.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182.2B USD | 4.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
137.2B USD | 18.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.9B USD | 6.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.1B USD | 3.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108.3B USD | 7.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.1B USD | 4.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.7B EUR | 3.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52.2B USD | 8.3 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.5B CNY | 9.7 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.3B USD | 13.1 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
3.3
2-Years Forward
EV/S
3.1
3-Years Forward
EV/S
2.8
You don't have any saved screeners yet
